Every lot published · search any lot number before you order

What Is Retatrutide? The Triple Agonist Explained

Retatrutide, also known as LY3437943, is an investigational peptide designed to activate the GLP-1, GIP and glucagon receptors. The three receptor targets are features of the molecule’s design.

What Is Retatrutide? The Triple Agonist Explained. GLP-1, GIP and glucagon. Molecule, Receptor targets, Human evidence. GLP LIFE SCIENCES · RESEARCH BRIEF 01 GLP-1, GIP and glucagon Foundations MoleculeReceptor targetsHuman evidence
GLP-1, GIP and glucagon. Illustration for this research brief.

GLP-1, GIP and glucagon

A receptor description gives researchers a way to test hypotheses about metabolism. Clinical trials then measure outcomes in people and record harms. Neither the count of targets nor the name of a receptor quantifies the effect on body weight.

How to interpret the evidence

Look for a source that distinguishes laboratory receptor experiments from randomized clinical outcomes. Phase 2 obesity data supply an early human comparison against placebo.

Start with the intervention name and receptor targets, then follow the links to the original trial if you want to check what was measured in people.

Sources